Harnessing Nature for Biotechnology
Innovating for a Sustainable Tomorrow. Breakthrough therapies powered by natural immunity.
Who Are We?
LimeRiver is a fully integrated biosciences company dedicated to the discovery and development of therapeutic antibodies derived from natural human immunity
LimeRiver's True Human™ antibody candidates are actually derived from donors with natural human immunity. No other marketed antibody product — including "humanized" and so-called "fully human" — are actually derived from natural human immunity.
About Us →Clinical Research
Therapeutic Areas
Discover our extraordinary innovation and success.
Latest News
News & Updates
Jun 18, 2024
LimeRiver Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer.
Read More →Jan 4, 2024
LimeRiver to Begin Constructing New R&D Facility on its 48-acre Campus.
Read More →Nov 14, 2023
Dr. Alan Kivitz to Chair LimeRiver's Natrunix Program in Rheumatoid Arthritis.
Read More →Technology
Where Cutting-Edge BioTechnology Meets Natural Human Immunity
True Humanâ„¢ Antibodies
Harnessing natural human antibody immunity — an intuitive approach to a new generation of medicines.
Manufacturing
State-of-the-art made simple. Engineered, designed and developed at LimeRiver.
Pipeline
Unveiling the Future of Medicine: Our Pioneering Pipeline of True Human Antibodies
Our pipeline addresses a wide range of unmet medical needs.